Skip to content

Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia

Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00572104
Enrollment
38
Registered
2007-12-12
Start date
2008-01-31
Completion date
2013-11-30
Last updated
2016-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopenia

Brief summary

This study will compare the ability of two types of long term (12 months) weight-bearing exercise treatments (1. high-intensity jumping and 2. weight lifting) to increase bone mass of the total body, spine and hip in physically active men with osteopenia.

Detailed description

The overall goal of this project is to determine the efficacy of chronic (12 months) plyometric jump training exercise on bone mineral density (BMD) and markers of bone turnover in physically active males cyclists diagnosed with osteopenia below normal bone mineral density of the lumbar spine or hip.

Interventions

OTHERresistance exercise

12 month training intervention of weight resistance exercise. All participants receive a daily calcium and vitamin D supplement

OTHERplyometric exercise

12 month training intervention of plyometric exercise. All participants receive a daily calcium and vitamin D supplement

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male * Age 25-60 years * No symptoms of disease * Currently participating in cycling activities an average of 4 hr/wk for the previous 24 months * Osteopenia of the lumbar spine and/or hip (T score \< -1.0 and \> -2.5 )

Exclusion criteria

* Medications or supplements that affect bone metabolism or prevent exercise * Previous or current medical condition affecting bone health * Osteoporosis of the lumbar spine and/or hip (T score \> -1.0 or \< -2.5) * Cardiovascular disease * Metallic implants * Current smoker * Current regular participation in high-intensity resistance training and/or plyometrics

Design outcomes

Primary

MeasureTime frame
Bone Mineral Density12 months

Secondary

MeasureTime frame
Serum markers of bone turnover3 months
Serum hormones regulating bone turnover3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026